Leading innovator in the design of automated minimally invasive neuro and spinal tissue and tumor removal instruments.


Keyhole surgery ‘a revolution’ in brain cancer treatment

New device that has saved thousands of lives in the US could double the number of British patients getting lifesaving operations.

NICO Announces CE Mark for BrainPath® Non-Disruptive Cranial Access Technology

“We’re very excited to be the first in the UK to offer this technology.”

NICO Announces First Patient Enrolled in Phase 3 Randomized Controlled Trial on Early Intervention of Hemorrhagic Stroke, Deadliest Form of Stroke

Indianapolis Medical device maker NICO Corporation today announced the enrollment of the first patient in the ENRICH (Early MiNimally-invasive Removal of ICH) randomized clinical trial.

Navigating the Value Analysis Committee

To provide medical device and technology companies with a greater perspective on successfully navigating VACs, we spoke with four River Cities’ med tech portfolio companies that have dedicated countless hours to mastering the pathway to get innovative products in front of and approved by these ever-vigilant committees.

Two Major Publications Reveal New Study Data Showing Patients with Deadliest Form of Stroke Now Have Second Chance at Life

New evidence in hemorrhagic stroke care suggests there may now be an answer for safely treating the deadliest, most costly and debilitating form of stroke through early surgical intervention.

Page 1 of 612345...Last »




River Cities Fund IV

Year Invested


City and State

Indianapolis, IN

Portfolio Manager

Carter McNabb